NRX Pharmaceuticals, Inc. Interest Expense
NRX Pharmaceuticals, Inc. (NRXP) reported Interest Expense of $230.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-14
- NRX Pharmaceuticals, Inc. interest expense for the quarter ending 2024-03-31 was $230.00K.
- NRX Pharmaceuticals, Inc. interest expense for the quarter ending 2023-12-31 was $80.00K.
- NRX Pharmaceuticals, Inc. interest expense for the quarter ending 2023-09-30 was $40.00K.
- NRX Pharmaceuticals, Inc. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. interest expense for fiscal 2023 was $120.00K.
- NRX Pharmaceuticals, Inc. interest expense for fiscal 2021 was $18.00K, a 67.86% decline from fiscal 2020.
- NRX Pharmaceuticals, Inc. interest expense for fiscal 2020 was $56.00K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | $230.00K 10-Q · filed 2024-05-14 | $310.00K derived: sum of 2 quarters · filed 2024-05-14 | $350.00K derived: sum of 3 quarters · filed 2024-05-14 | ||||
| 2023-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $120.00K derived: sum of 2 quarters · filed 2024-03-29 | $120.00K 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | $40.00K 10-Q · filed 2023-11-14 | $40.00K 10-Q · filed 2023-11-14 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $3.00K 10-Q · filed 2023-11-14 | $5.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.00K 10-Q · filed 2023-08-14 | $5.00K derived: sum of 3 quarters · filed 2023-08-14 | $10.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $3.00K 10-Q · filed 2023-05-15 | $5.00K derived: sum of 2 quarters · filed 2023-05-15 | $10.00K derived: sum of 3 quarters · filed 2023-05-15 | $15.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.00K derived: sum of 2 quarters · filed 2023-03-31 | $12.00K derived: sum of 3 quarters · filed 2023-03-31 | $18.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-14 | $5.37K 10-Q · filed 2021-11-15 | $10.00K derived: sum of 2 quarters · filed 2022-11-14 | $16.00K 10-Q · filed 2022-11-14 | $15.66K 10-Q · filed 2021-11-15 | $19.68K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-15 | $5.11K 10-Q · filed 2021-08-16 | $10.00K 10-Q · filed 2022-08-15 | $10.29K 10-Q · filed 2021-08-16 | $14.68K derived: sum of 3 quarters · filed 2022-08-15 | $27.20K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-16 | $9.68K derived: sum of 2 quarters · filed 2022-05-16 | $22.20K derived: sum of 3 quarters · filed 2022-08-12 | $24.73K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2020-12-31 | $4.68K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $17.20K derived: sum of 2 quarters · filed 2022-08-12 | $19.73K derived: sum of 3 quarters · filed 2022-08-12 | $56.00K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $12.51K 10-Q/A · filed 2022-08-12 | $15.04K derived: sum of 2 quarters · filed 2022-08-12 | $51.32K 10-Q/A · filed 2022-08-12 | ||||
| 2020-06-30 | $2.53K 10-Q/A · filed 2022-08-12 | $38.80K 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |